Shrinks In Sneakers

Tag: mental health

🚨 AI Predicting Schizophrenia & Bipolar Disorder? Not So Fast…
A new study trained an AI model on 24,000+ electronic health records (EHRs) to predict whether a patient would develop schizophrenia or bipolar disorder. The results? 🤔

🔍 The XGBoost machine learning model showed better performance for schizophrenia than bipolar disorder.
📊 It achieved an AUC of 0.70 on training data and 0.64 on the test set.
⚠️ But here’s the catch: despite 96.3% specificity, the model’s sensitivity was just 9.3%, meaning it missed the vast majority of cases.

💡 Bottom Line: AI in psychiatry is promising, but we’re not at the point where a model like this could reliably flag patients at risk. High specificity sounds great—until you realize the trade-off is missing 90%+ of those who actually transition to schizophrenia or bipolar disorder.

Will future AI tools get better at predicting these life-altering conditions? Time (and data) will tell. ⏳
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 22, 2025
The Most Commonly Prescribed Medication for Bipolar Disorder… But Is It the Best?
When it comes to bipolar disorder, the most commonly prescribed medication isn’t necessarily the most effective.Many clinicians default to prescribing quetiapine, valproate, or lamotrigine, yet lithium remains the gold standardfor long-term treatment.

So, why is lithium often overlooked? Despite decades of evidence supporting its unmatched efficacy in preventing relapse, reducing suicide risk, and stabilizing mood long-term, lithium is underprescribed due to concerns over side effects, monitoring requirements, and physician discomfort with its use.

🔹 What Do the RCTs Say About Lithium?

✅ BALANCE Trial (2010) – The landmark study comparing lithium vs. valproate vs. combination therapy found that lithium monotherapy was superior to valproate in preventing relapse into both manic and depressive episodes (Geddes et al., 2010).

✅ NIMH STEP-BD Trial (2005) – Among mood stabilizers, lithium significantly reduced suicide risk, a benefit not shared by other common treatments (Goodwin et al., 2003).

✅ Cade’s Legacy and Beyond – Multiple meta-analyses confirm that lithium reduces relapse rates and is the only mood stabilizer with strong anti-suicidal effects (Cipriani et al., 2005).

🚨 The Bottom Line? Lithium is STILL the most effective long-term treatment for bipolar disorder, yet it is often underutilized. Instead, newer and more expensive alternatives are frequently prescribed—even when they lack lithium’s robust evidence base.

Yes, lithium requires monitoring. Yes, it comes with side effects. But for patients with bipolar disorder, choosing the right medication can mean the difference between stability and relapse, life and death.

Let’s start prescribing based on data, not convenience. 🔥
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 21, 2025
🚨 Mania with Mixed Features: The Ultimate Mood Storm 🌪️
Bipolar mania is intense—but when mixed features are present, it’s a whole different beast. Imagine sky-high energy ⚡ + crushing despair 😞 at the same time. That’s mixed mania—one of the most challenging and high-risk mood states in psychiatry.

🔍 What Does It Look Like?

✅ Racing thoughts 🏎️ + Hopelessness 😔
✅ Insomnia for days 🌙 + Feeling exhausted 😴
✅ Irritability 🔥 + Tearfulness 😢
✅ Grandiosity 👑 + Suicidal thoughts 🚨
✅ Restless energy ⚡ + No pleasure in anything ❌

🚑 Why It’s High Risk

Patients with mania + mixed features have:
⚠️ Higher suicide risk than pure mania
⚠️ More agitation & impulsivity
⚠️ Less response to traditional mood stabilizers

🛑 Treatment Challenges

❌ Antidepressants can worsen symptoms
✅ Mood stabilizers (lithium, valproate) & atypical antipsychotics (quetiapine, olanzapine, lurasidone) are key
✅ Careful monitoring is essential

💡 Takeaway: Mixed mania isn’t just “agitated depression” or “irritable mania”—it’s a unique, dangerous mood state that requires urgent intervention. Recognizing it early can save lives.

Have you encountered mixed mania in practice? Let’s discuss! 👇
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 20, 2025
🔍 Suicide & Psychosis: What We Can Learn from Recent Research
A new study sheds light on suicide risk in patients with psychotic disorders, comparing those with recent-onset schizophrenia or other psychotic disorders to those with longer illness duration. The findings offer critical insights for clinicians and mental health professionals.

🚨 Key Takeaways:

📌 Early Illness = Higher Risk: Patients within the first five years of their illness had higher suicide rates, emphasizing the need for intensive early intervention.

📌 Common Risk Factors: Across both groups, depression, prior suicide attempts, and substance use were major red flags.

📌 Different Patterns: Those with recent-onset psychosis were more likely to have rapid illness progression, while those with longer illness duration often had chronic distress and social isolation before suicide.

📌 Missed Opportunities? Many had recent healthcare encounters before suicide, highlighting potential gaps in risk assessment and intervention.

🛑 What This Means for Us:
🔹 Early-phase psychosis care should prioritize suicide prevention.
🔹 Screening for depression, substance use, and prior attempts is essential.
🔹 More proactive intervention is needed, especially after hospital visits.

This study reinforces what many frontline clinicians already suspect—suicide prevention in psychosis requires urgent, tailored strategies. How can we improve early detection and support for at-risk patients? Let’s discuss. 👇
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 19, 2025
The Pill Won’t Solve It All 💊🚫
When every problem you face has been treated exclusively by a pill, you start to believe that the answer to all your struggles lies in finding the right one. 🤔💡

With this mindset, you will never be well. 🧠❌

It’s no different than someone searching for the perfect car 🚗 or the dream home 🏡 to fix their life. Sure, it might bring temporary relief, but in the end, it steals your power, leaving your happiness dependent on external factors you can’t control. 🎭🔗

True healing starts when you reclaim your own agency. 💪🔥
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 17, 2025
Semaglutide (#Ozempic / #Wegovy) Reduced Alcohol & Nicotine Use in a First-of-Its-Kind RCT
📉 In a randomized trial with 48 patients diagnosed with #AlcoholUseDisorder, semaglutide significantly lowered alcohol intake in a controlled lab setting.

🚬 Interestingly, nicotine consumption also decreased.

💉 Low doses (0.25-1 mg/week) were used over 9 weeks—much lower than standard obesity or diabetes dosing.

🔬 More research is needed, but this adds to growing evidence that GLP-1 agonists may impact addictive behaviors.

Link to article: https://pubmed.ncbi.nlm.nih.gov/39937469/
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 14, 2025
🚨 New JAMA Study: Cannabis Legalization & Schizophrenia
A groundbreaking study just dropped in JAMA Psychiatry, shedding light on the link between cannabis use disorder (CUD) and schizophrenia following cannabis legalization.

📊 Key Findings:
- Higher rates of schizophrenia diagnoses were observed in young men with CUD after legalization.
- The association was strongest in males aged 18–24, a group already at high risk for schizophrenia onset.
- No significant changes were found in individuals without CUD, reinforcing concerns about cannabis as a potential trigger in vulnerable populations.
🧠 What This Means:
Cannabis legalization doesn’t just increase access—it may be shifting the trajectory of severe mental illness in at-risk groups. While correlation ≠ causation, this study adds weight to the argument that heavy cannabis use isn’t harmless, especially for young people with genetic or neurodevelopmental vulnerabilities.

⚖️ Clinical & Policy Implications:
- Should we rethink cannabis policy in light of these findings?
- Do we need stronger public health messaging about the psychiatric risks of heavy cannabis use?
- How can we better screen and intervene early for CUD in young men?
As psychiatrists, we see these cases firsthand—the young man with new-onset psychosis, the family blindsided, the struggle to regain lost cognitive and social function.

This study is a wake-up call. Legal ≠ safe for everyone.

What are your thoughts? Should legalization come with more psychiatric safeguards? Drop your insights below. ⬇️
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 13, 2025
🚨 Double Trouble? The Evidence on Combining Z-Drugs & Benzos 💊⚡
If you live long enough, you’ll see some crazy stuff 🤯. I believe in the art of psychopharmacology 🎨💊, and I’m a gunslinger who enjoys pushing the limits 🔫—but some things are just plain nuts. Buckle up for this one… 🚀⚡

There is limited high-quality randomized controlled trial (RCT) evidence supporting the combined use of benzodiazepines and Z-drugs (zolpidem, eszopiclone, zaleplon). Most studies on these drug classes focus on their use individually for insomnia or anxiety, and guidelines generally discourage their concurrent use due to concerns about additive sedative effects, increased risk of dependence, cognitive impairment, falls, and respiratory depression.

RCT Evidence on Combination Use
1. Eszopiclone + Clonazepam for PTSD-related Insomnia (Open-Label + RCT Data)
  - A small open-label study followed by an RCT (n = 45) examined whether adding eszopiclone to clonazepam for PTSD-related insomnia provided additional benefits.
  - Results showed that while sleep latency and duration improved slightly with combination therapy, adverse effects (e.g., sedation, next-day drowsiness) were more pronounced.
  - Conclusion: Modest benefits in sleep but significant risks.
2. Zolpidem + Diazepam for Insomnia in Anxiety Disorders (Crossover RCT, n = 30)
  - A crossover RCT investigated whether combining zolpidem (10 mg) with diazepam (5 mg) improved sleep quality in patients with generalized anxiety disorder.
  - The combination improved sleep efficiency compared to diazepam alone but led to increased daytime drowsiness and mild cognitive impairment.
  - Conclusion: Minimal additional sleep benefit with worsened side effects.
3. Eszopiclone + Lorazepam for Acute Mania (Adjunctive RCT, n = 60)
  - In a study of patients with acute mania receiving standard treatment, those given eszopiclone in addition to lorazepam had better subjective sleep outcomes.
  - However, no significant differences were found in mania symptom reduction, and the combination increased next-day sedation.
  - Conclusion: Sleep improvement but with notable sedation risks.
Meta-Analyses & Guidelines
- No major meta-analyses support combination use.
- Clinical guidelines (e.g., APA, ASAM) strongly discourage combining these drugs due to risks of dependence, respiratory depression, and falls, particularly in older adults.
Summary

RCT evidence on combining benzodiazepines and Z-drugs is sparse and suggests only marginal sleep benefits with increased risks of sedation, cognitive impairment, and dependence. Guidelines advise against their concurrent use outside of specific, short-term clinical scenarios.
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 12, 2025
🚨 Five Things That Will Guarantee Unhappiness, Depression, and Anxiety
From a psychiatrist’s perspective, if you want to be miserable, just focus on these:

1️⃣ Materialism 💰📱🚗 – The more you obsess over what you have (or don’t have), the more dissatisfied you’ll be. Nothing external ever fills the internal void.

2️⃣ Society’s Definition of Success 📈🎓🏆 – Chasing achievement based on external validation will leave you constantly feeling behind. The finish line always moves.

3️⃣ Vanity & Appearance 💄💪📸 – If your self-worth is tied to body shape, beauty, or attractiveness, you’ll never feel “good enough.” Looks fade. Confidence lasts.

4️⃣ Money 🏦💵📊 – There will always be someone richer. If wealth is your purpose, you’ll forever be chasing the next dollar instead of fulfillment.

5️⃣ Status & Social Hierarchy 👑🎭📣 – Measuring your worth by your rank in society, work, or even spirituality will keep you trapped in comparison. The ego is never satisfied.

These are simple truths we all know… but knowing and living them are two entirely different things. 💡

#MentalHealth #PerspectiveShift #FulfillmentOverComparison
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 10, 2025
🚨 New Study: Cannabis Use Disorder Linked to 3X Higher Mortality in Hospital & ER Patients
A major new study has uncovered a staggering risk: Patients diagnosed with Cannabis Use Disorder (CUD) in hospitals or ERs had nearly THREE TIMES the mortality rate over the next five years compared to those without the disorder.

🔎 Key Findings:

🛑 Patients with CUD had a significantly higher risk of death within five years.

🛑 Cannabis use was associated with worse health outcomes, even after adjusting for other factors.

🛑 Findings challenge the assumption that cannabis is a “harmless” substance.

💡 Why This Matters:

As cannabis use becomes more common and legalized, we can’t ignore the potential long-term health consequences—especially in vulnerable populations. This study raises urgent questions about how cannabis impacts physical and mental health in the long run.

📢 What do you think? Should we be taking Cannabis Use Disorder more seriously in medical settings? Drop your thoughts below! 👇

🔗 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2829914

#Cannabis #PublicHealth #Addiction #ER #Medicine #addictionmedicine #addiction #cannabisusedisorder #addictionpsychiatry #medical #doctor #medication #marijuana
Share this:
X
Facebook
LinkedIn
Reddit
WhatsApp
Email
Like this:
Like Loading…
February 7, 2025